awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37627876-0E5FC642-7CF9-41CD-A43D-F44B97D18866
Q37627876-0E5FC642-7CF9-41CD-A43D-F44B97D18866
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37627876-0E5FC642-7CF9-41CD-A43D-F44B97D18866
Pharmacogenomics in acute myeloid leukemia.
P2860
Q37627876-0E5FC642-7CF9-41CD-A43D-F44B97D18866
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37627876-0E5FC642-7CF9-41CD-A43D-F44B97D18866
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
34e0b53774063bf44ba1eeaa9678a18f6699acec
P2860
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study